154 related articles for article (PubMed ID: 23179081)
21. Phthalate induction of CYP3A4 is dependent on glucocorticoid regulation of PXR expression.
Cooper BW; Cho TM; Thompson PM; Wallace AD
Toxicol Sci; 2008 Jun; 103(2):268-77. PubMed ID: 18332045
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cynomolgus monkey pregnane X receptor, primary hepatocyte, and in vivo pharmacokinetic changes in predicting human CYP3A4 induction.
Kim S; Dinchuk JE; Anthony MN; Orcutt T; Zoeckler ME; Sauer MB; Mosure KW; Vuppugalla R; Grace JE; Simmermacher J; Dulac HA; Pizzano J; Sinz M
Drug Metab Dispos; 2010 Jan; 38(1):16-24. PubMed ID: 19833845
[TBL] [Abstract][Full Text] [Related]
23. Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.
Pondugula SR; Flannery PC; Abbott KL; Coleman ES; Mani S; Samuel T; Xie W
Toxicol Lett; 2015 Feb; 232(3):580-9. PubMed ID: 25542144
[TBL] [Abstract][Full Text] [Related]
24. Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR.
Luckert C; Ehlers A; Buhrke T; Seidel A; Lampen A; Hessel S
Toxicol Lett; 2013 Oct; 222(2):180-8. PubMed ID: 23845848
[TBL] [Abstract][Full Text] [Related]
25. [Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors].
Rioja Zuazu J; Bandrés Elizalde E; Rosell Costa D; Rincón Mayans A; Zudaire Bergera J; Gil Sanz MJ; Rioja Sanz LA; García Foncillas J; Berián Polo JM
Actas Urol Esp; 2007; 31(10):1107-16. PubMed ID: 18314648
[TBL] [Abstract][Full Text] [Related]
26. Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma.
Kroiss M; Quinkler M; Lutz WK; Allolio B; Fassnacht M
Clin Endocrinol (Oxf); 2011 Nov; 75(5):585-91. PubMed ID: 21883349
[TBL] [Abstract][Full Text] [Related]
27. Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement.
Chortis V; Taylor AE; Schneider P; Tomlinson JW; Hughes BA; O'Neil DM; Libé R; Allolio B; Bertagna X; Bertherat J; Beuschlein F; Fassnacht M; Karavitaki N; Mannelli M; Mantero F; Opocher G; Porfiri E; Quinkler M; Sherlock M; Terzolo M; Nightingale P; Shackleton CH; Stewart PM; Hahner S; Arlt W
J Clin Endocrinol Metab; 2013 Jan; 98(1):161-71. PubMed ID: 23162091
[TBL] [Abstract][Full Text] [Related]
28. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation.
Zhou C; Tabb MM; Nelson EL; Grün F; Verma S; Sadatrafiei A; Lin M; Mallick S; Forman BM; Thummel KE; Blumberg B
J Clin Invest; 2006 Aug; 116(8):2280-2289. PubMed ID: 16841097
[TBL] [Abstract][Full Text] [Related]
29. Interaction of silencing mediator for retinoid and thyroid receptors with steroid and xenobiotic receptor on multidrug resistance 1 promoter.
Hirooka-Masui K; Lesmana R; Iwasaki T; Xu M; Hayasaka K; Haraguchi M; Takeshita A; Shimokawa N; Yamamoto K; Koibuchi N
Life Sci; 2013 May; 92(17-19):911-5. PubMed ID: 23562850
[TBL] [Abstract][Full Text] [Related]
30. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.
Tirona RG; Lee W; Leake BF; Lan LB; Cline CB; Lamba V; Parviz F; Duncan SA; Inoue Y; Gonzalez FJ; Schuetz EG; Kim RB
Nat Med; 2003 Feb; 9(2):220-4. PubMed ID: 12514743
[TBL] [Abstract][Full Text] [Related]
31. Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways.
Li Y; Wang Q; Yao X; Li Y
Eur J Pharmacol; 2010 Aug; 640(1-3):46-54. PubMed ID: 20580705
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR.
Kawana K; Ikuta T; Kobayashi Y; Gotoh O; Takeda K; Kawajiri K
Mol Pharmacol; 2003 Mar; 63(3):524-31. PubMed ID: 12606758
[TBL] [Abstract][Full Text] [Related]
33. Investigation of Orlistat effects on PXR activation and CYP3A4 expression in primary human hepatocytes and human intestinal LS174T cells.
Novotna A; Doricakova A; Vrzal R; Maurel P; Pavek P; Dvorak Z
Eur J Pharm Sci; 2010 Oct; 41(2):276-80. PubMed ID: 20599501
[TBL] [Abstract][Full Text] [Related]
34. Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.
Theile D; Haefeli WE; Weiss J
Endocrine; 2015 Aug; 49(3):842-53. PubMed ID: 25542188
[TBL] [Abstract][Full Text] [Related]
35. Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding.
Istrate MA; Nussler AK; Eichelbaum M; Burk O
Biochem Biophys Res Commun; 2010 Mar; 393(4):688-93. PubMed ID: 20171174
[TBL] [Abstract][Full Text] [Related]
36. Pregnane X receptor polymorphism affects CYP3A4 induction via a ligand-dependent interaction with steroid receptor coactivator-1.
Lim YP; Huang JD
Pharmacogenet Genomics; 2007 May; 17(5):369-82. PubMed ID: 17429319
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.
Niu Y; Wu Z; Shen Q; Song J; Luo Q; You H; Shi G; Qin W
Dig Liver Dis; 2013 Dec; 45(12):1041-8. PubMed ID: 23891548
[TBL] [Abstract][Full Text] [Related]
38. The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor.
Ding X; Lichti K; Staudinger JL
Toxicol Sci; 2006 Jun; 91(2):448-55. PubMed ID: 16547076
[TBL] [Abstract][Full Text] [Related]
39. The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells.
Takeshita A; Inagaki K; Igarashi-Migitaka J; Ozawa Y; Koibuchi N
J Endocrinol; 2006 Sep; 190(3):897-902. PubMed ID: 17003290
[TBL] [Abstract][Full Text] [Related]
40. Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor.
Chen Y; Tang Y; Nie JZ; Zhang Y; Nie D
Cancer Chemother Pharmacol; 2021 Dec; 88(6):985-996. PubMed ID: 34524495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
